MetLife Investment Management’s Genesco GCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $200K | Hold |
5,927
| – | – | ﹤0.01% | 2416 |
|
|
2026
Q1 | $172K | Buy |
5,927
+829
| +16% | +$23.8K | ﹤0.01% | 2303 |
|
|
2025
Q4 | $126K | Sell |
5,098
-1,688
| -25% | -$48.4K | ﹤0.01% | 2494 |
|
|
2025
Q3 | $197K | Hold |
6,786
| – | – | ﹤0.01% | 2324 |
|
|
2025
Q2 | $134K | Hold |
6,786
| – | – | ﹤0.01% | 2394 |
|
|
2025
Q1 | $144K | Sell |
6,786
-158
| -2% | -$5.5K | ﹤0.01% | 2367 |
|
|
2024
Q4 | $297K | Hold |
6,944
| – | – | ﹤0.01% | 2078 |
|
|
2024
Q3 | $189K | Hold |
6,944
| – | – | ﹤0.01% | 2318 |
|
|
2024
Q2 | $180K | Buy |
6,944
+673
| +11% | +$17.6K | ﹤0.01% | 2319 |
|
|
2024
Q1 | $176K | Hold |
6,271
| – | – | ﹤0.01% | 2262 |
|
|
2023
Q4 | $221K | Hold |
6,271
| – | – | ﹤0.01% | 2190 |
|
|
2023
Q3 | $193K | Hold |
6,271
| – | – | ﹤0.01% | 2232 |
|
|
2023
Q2 | $157K | Hold |
6,271
| – | – | ﹤0.01% | 2412 |
|
|
2023
Q1 | $231K | Sell |
6,271
-1,028
| -14% | -$45K | ﹤0.01% | 2133 |
|
|
2022
Q4 | $336K | Sell |
7,299
-508
| -7% | -$23.1K | ﹤0.01% | 1893 |
|
|
2022
Q3 | $307K | Hold |
7,807
| – | – | ﹤0.01% | 2005 |
|
|
2022
Q2 | $390K | Hold |
7,807
| – | – | ﹤0.01% | 1838 |
|
|
2022
Q1 | $497K | Buy |
7,807
+2,818
| +56% | +$183K | ﹤0.01% | 1776 |
|
|
2021
Q4 | $320K | Hold |
4,989
| – | – | ﹤0.01% | 1773 |
|
|
2021
Q3 | $288K | Sell |
4,989
-1,368
| -22% | -$81.4K | ﹤0.01% | 1847 |
|
|
2021
Q2 | $405K | Hold |
6,357
| – | – | ﹤0.01% | 1698 |
|
|
2021
Q1 | $302K | Hold |
6,357
| – | – | ﹤0.01% | 1808 |
|
|
2020
Q4 | $191K | Hold |
6,357
| – | – | ﹤0.01% | 2008 |
|
|
2020
Q3 | $137K | Hold |
6,357
| – | – | ﹤0.01% | 2072 |
|
|
2020
Q2 | $138K | Hold |
6,357
| – | – | ﹤0.01% | 2098 |
|
|
2020
Q1 | $84.8K | Hold |
6,357
| – | – | ﹤0.01% | 2168 |
|
|
2019
Q4 | $305K | Hold |
6,357
| – | – | ﹤0.01% | 1738 |
|
|
2019
Q3 | $254K | Sell |
6,357
-2,326
| -27% | -$89.8K | ﹤0.01% | 1810 |
|
|
2019
Q2 | $367K | Sell |
8,683
-17,366
| -67% | -$768K | ﹤0.01% | 1661 |
|
|
2019
Q1 | $1.19M | Buy |
26,049
+17,366
| +200% | +$796K | ﹤0.01% | 1561 |
|
|
2018
Q4 | $385K | Hold |
8,683
| – | – | ﹤0.01% | 1529 |
|
|
2018
Q3 | $409K | Hold |
8,683
| – | – | ﹤0.01% | 1653 |
|
|
2018
Q2 | $345K | Hold |
8,683
| – | – | ﹤0.01% | 1633 |
|
|
2018
Q1 | $353K | Hold |
8,683
| – | – | ﹤0.01% | 1589 |
|
|
2017
Q4 | $282K | Buy |
+8,683
| New | +$239K | ﹤0.01% | 1746 |
|
Other funds holding GCO
F1I
MetLife Investment Management's GCO Position: Q2 2026 in Review
MetLife Investment Management held its Genesco (GCO) position steady in Q2 2026 at 5,927 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.
MetLife Investment Management first reported a position in GCO in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.19M in Q1 2019. 142 funds tracked by Wall St. Rank hold GCO as of Q2 2026.
- MetLife Investment Management held 5,927 shares of Genesco worth $200K as of Q2 2026.
- MetLife Investment Management left its Genesco share count unchanged in Q2 2026.
- Genesco made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2416 holding.
- MetLife Investment Management first reported a position in Genesco in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Genesco position peaked at $1.19M in Q1 2019.
- 142 funds tracked by Wall St. Rank held Genesco as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.